Annual Non Current Assets
$8.57 M
-$40.56 M-82.55%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual long term assets is currently $8.57 million, with the most recent change of -$40.56 million (-82.55%) on 31 December 2023. During the last 3 years, it has risen by +$8.11 million (+1739.70%). ACRV annual non current assets is now -82.55% below its all-time high of $49.13 million, reached on 31 December 2022.ACRV Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$25.70 M
-$22.53 M-46.71%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly long term assets is currently $25.70 million, with the most recent change of -$22.53 million (-46.71%) on 30 September 2024. Over the past year, it has increased by +$19.10 million (+289.39%). ACRV quarterly non current assets is now -47.69% below its all-time high of $49.13 million, reached on 31 December 2022.ACRV Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -82.5% | +289.4% |
| 3 y3 years | +1739.7% | +315.9% |
| 5 y5 years | - | - |
ACRV Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -82.5% | +1739.7% | -47.7% | +315.9% |
| 5 y | 5 years | -82.5% | +1739.7% | -47.7% | +315.9% |
| alltime | all time | -82.5% | +1739.7% | -47.7% | +315.9% |
Acrivon Therapeutics Common Stock Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $25.70 M(-46.7%) |
| June 2024 | - | $48.23 M(+475.6%) |
| Mar 2024 | - | $8.38 M(-2.3%) |
| Dec 2023 | $129.69 M | $8.57 M(+29.9%) |
| Sept 2023 | - | $6.60 M(-2.5%) |
| June 2023 | - | $6.77 M(-85.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $46.23 M(-5.9%) |
| Dec 2022 | $132.09 M(+31.6%) | $49.13 M(+443.4%) |
| Sept 2022 | - | $9.04 M(+15.4%) |
| June 2022 | - | $7.83 M(+26.8%) |
| Dec 2021 | $100.41 M(+5741.1%) | - |
| Dec 2021 | - | $6.18 M |
| Dec 2020 | $1.72 M | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual long term assets?
- What is the all time high annual non current assets for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual non current assets year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly long term assets?
- What is the all time high quarterly non current assets for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly non current assets year-on-year change?
What is Acrivon Therapeutics Common Stock annual long term assets?
The current annual non current assets of ACRV is $8.57 M
What is the all time high annual non current assets for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual long term assets is $49.13 M
What is Acrivon Therapeutics Common Stock annual non current assets year-on-year change?
Over the past year, ACRV annual long term assets has changed by -$40.56 M (-82.55%)
What is Acrivon Therapeutics Common Stock quarterly long term assets?
The current quarterly non current assets of ACRV is $25.70 M
What is the all time high quarterly non current assets for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly long term assets is $49.13 M
What is Acrivon Therapeutics Common Stock quarterly non current assets year-on-year change?
Over the past year, ACRV quarterly long term assets has changed by +$19.10 M (+289.39%)